Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
REM Medical is an Israeli medical technology company focused on developing a novel, minimally invasive treatment for obstructive sleep apnea (OSA). The company's lead technology is a procedural solution designed to maintain airway patency during sleep, offering a long-term alternative to Continuous Positive Airway Pressure (CPAP) therapy. By addressing the common issues of patient discomfort and low compliance associated with traditional treatments, REM Medical aims to provide a more effective and patient-friendly intervention for the millions suffering from OSA. The company is currently advancing its technology through clinical feasibility studies and is part of the Alon MedTech Ventures portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on REM Medical.